CoChat
Sign Up
Cited by 114

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

APP/PS1 mice overexpressing SREBP-2 exhibit combined Aβ accumulation and tau pathology underlying Alzheimer's disease

Barbero-Camps, Elisabet, Fernández, Anna, Martínez, Laura, Fernández-Checa, Jose C., Colell, Anna·2013·Human Molecular Genetics
DOI 10.1093/hmg/ddt201
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/hmg/ddt201

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 74

  1. Cutler, 2004, Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease, Proc. Natl Acad. Sci. USA, 101, 2070, 10.1073/pnas.0305799101 · DOI · Paper page
  2. Bandaru, 2009, ApoE4 disrupts sterol and sphingolipid metabolism in Alzheimer's but not normal brain, Neurobiol. Aging, 30, 591, 10.1016/j.neurobiolaging.2007.07.024 · DOI
  3. Xiong, 2008, Cholesterol retention in Alzheimer's brain is responsible for high beta- and gamma-secretase activities and Abeta production, Neurobiol. Dis., 29, 422, 10.1016/j.nbd.2007.10.005 · DOI
  4. Panchal, 2010, Enrichment of cholesterol in microdissected Alzheimer's disease senile plaques as assessed by mass spectrometry, J. Lipid Res., 51, 598, 10.1194/jlr.M001859 · DOI
  5. Fernandez, 2009, Mitochondrial cholesterol loading exacerbates amyloid beta peptide-induced inflammation and neurotoxicity, J. Neurosci., 29, 6394, 10.1523/JNEUROSCI.4909-08.2009 · DOI
  6. Shepardson, 2011, Cholesterol level and statin use in Alzheimer disease: I. Review of epidemiological and preclinical studies, Arch. Neurol., 68, 1239, 10.1001/archneurol.2011.203 · DOI
  7. Ehehalt, 2003, Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts, J. Cell Biol., 160, 113, 10.1083/jcb.200207113 · DOI · Paper page
  8. Kalvodova, 2005, Lipids as modulators of proteolytic activity of BACE: involvement of cholesterol, glycosphingolipids, and anionic phospholipids in vitro, J. Biol. Chem., 280, 36815, 10.1074/jbc.M504484200 · DOI
  9. Osenkowski, 2008, Direct and potent regulation of gamma-secretase by its lipid microenvironment, J. Biol. Chem., 283, 22529, 10.1074/jbc.M801925200 · DOI
  10. Yip, 2001, Cholesterol, a modulator of membrane-associated Abeta-fibrillogenesis and neurotoxicity, J. Mol. Biol., 311, 723, 10.1006/jmbi.2001.4881 · DOI
  11. Grimm, 2005, Regulation of cholesterol and sphingomyelin metabolism by amyloid-beta and presenilin, Nat. Cell Biol., 7, 1118, 10.1038/ncb1313 · DOI
  12. Liu, 2007, Amyloid precursor protein regulates brain apolipoprotein E and cholesterol metabolism through lipoprotein receptor LRP1, Neuron, 56, 66, 10.1016/j.neuron.2007.08.008 · DOI · Paper page
  13. Bryleva, 2010, ACAT1 gene ablation increases 24(S)-hydroxycholesterol content in the brain and ameliorates amyloid pathology in mice with AD, Proc. Natl Acad. Sci. USA, 107, 3081, 10.1073/pnas.0913828107 · DOI · Paper page
  14. Yao, 2012, Neuroprotection by cyclodextrin in cell and mouse models of Alzheimer disease, J. Exp. Med., 209, 2501, 10.1084/jem.20121239 · DOI
  15. Colell, 2009, Mitochondria, cholesterol and amyloid beta peptide: a dangerous trio in Alzheimer disease, J. Bioenerg. Biomembr., 41, 417, 10.1007/s10863-009-9242-6 · DOI
  16. Ashe, 2010, Probing the biology of Alzheimer's disease in mice, Neuron, 66, 631, 10.1016/j.neuron.2010.04.031 · DOI · Paper page
  17. Chabrier, 2012, Soluble abeta promotes wild-type tau pathology in vivo, J. Neurosci., 32, 17345, 10.1523/JNEUROSCI.0172-12.2012 · DOI · Paper page
  18. Jin, 2011, Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration, Proc. Natl Acad. Sci. USA, 108, 5819, 10.1073/pnas.1017033108 · DOI · Paper page
  19. Tokutake, 2012, Hyperphosphorylation of Tau induced by naturally secreted amyloid-beta at nanomolar concentrations is modulated by insulin-dependent Akt-GSK3beta signaling pathway, J. Biol. Chem., 287, 35222, 10.1074/jbc.M112.348300 · DOI
  20. Melov, 2007, Mitochondrial oxidative stress causes hyperphosphorylation of tau, PLoS One, 2, e536, 10.1371/journal.pone.0000536 · DOI · Paper page
  21. Distl, 2001, Tangle-bearing neurons contain more free cholesterol than adjacent tangle-free neurons, Acta Neuropathol., 101, 547, 10.1007/s004010000314 · DOI
  22. Love, 1995, Neurofibrillary tangles in Niemann-Pick disease type C, Brain, 118, 119, 10.1093/brain/118.1.119 · DOI
  23. Yu, 2005, Altered cholesterol metabolism in Niemann-Pick type C1 mouse brains affects mitochondrial function, J. Biol. Chem., 280, 11731, 10.1074/jbc.M412898200 · DOI
  24. Sawamura, 2001, Site-specific phosphorylation of tau accompanied by activation of mitogen-activated protein kinase (MAPK) in brains of Niemann-Pick type C mice, J. Biol. Chem., 276, 10314, 10.1074/jbc.M009733200 · DOI
  25. Burns, 2003, Presenilin redistribution associated with aberrant cholesterol transport enhances beta-amyloid production in vivo, J. Neurosci., 23, 5645, 10.1523/JNEUROSCI.23-13-05645.2003 · DOI
  26. Kodam, 2010, Altered levels and distribution of amyloid precursor protein and its processing enzymes in Niemann-Pick type C1-deficient mouse brains, Glia, 58, 1267, 10.1002/glia.21001 · DOI
  27. Maulik, 2012, Mutant human APP exacerbates pathology in a mouse model of NPC and its reversal by a beta-cyclodextrin, Hum. Mol. Genet., 21, 4857, 10.1093/hmg/dds322 · DOI
  28. Rahman, 2005, High cholesterol diet induces tau hyperphosphorylation in apolipoprotein E deficient mice, FEBS Lett., 579, 6411, 10.1016/j.febslet.2005.10.024 · DOI
  29. Games, 2006, Mice as models: transgenic approaches and Alzheimer's disease, J. Alzheimers Dis., 9, 133, 10.3233/JAD-2006-9S316 · DOI
  30. Yang, 2008, Neuronal apoptosis and autophagy cross talk in aging PS/APP mice, a model of Alzheimer's disease, Am. J. Pathol., 173, 665, 10.2353/ajpath.2008.071176 · DOI
  31. Sadowski, 2004, Amyloid-beta deposition is associated with decreased hippocampal glucose metabolism and spatial memory impairment in APP/PS1 mice, J. Neuropathol. Exp. Neurol., 63, 418, 10.1093/jnen/63.5.418 · DOI
  32. Brown, 2001, Recognition memory: what are the roles of the perirhinal cortex and hippocampus, Nat. Rev. Neurosci., 2, 51, 10.1038/35049064 · DOI
  33. Winters, 2004, Double dissociation between the effects of peri-postrhinal cortex and hippocampal lesions on tests of object recognition and spatial memory: heterogeneity of function within the temporal lobe, J. Neurosci., 24, 5901, 10.1523/JNEUROSCI.1346-04.2004 · DOI
  34. Mattsson, 2012, Amyloid-beta metabolism in Niemann-Pick C disease models and patients, Metab. Brain Dis., 27, 573, 10.1007/s11011-012-9332-8 · DOI
  35. Nishimura, 1995, Immunocytochemical characterization of glial fibrillary tangles in Alzheimer's disease brain, Am. J. Pathol., 146, 1052
  36. Rudrabhatla, 2011, Role of protein phosphatase 2A in Alzheimer's disease, Curr. Alzheimer Res., 8, 623, 10.2174/156720511796717168 · DOI
  37. Wang, 2007, Stepwise proteolysis liberates tau fragments that nucleate the Alzheimer-like aggregation of full-length tau in a neuronal cell model, Proc. Natl Acad. Sci. USA, 104, 10252, 10.1073/pnas.0703676104 · DOI
  38. Nicholson, 2009, Increased membrane cholesterol might render mature hippocampal neurons more susceptible to beta-amyloid-induced calpain activation and tau toxicity, J. Neurosci., 29, 4640, 10.1523/JNEUROSCI.0862-09.2009 · DOI
  39. Ma, 2009, Statin's excitoprotection is mediated by sAPP and the subsequent attenuation of calpain-induced truncation events, likely via rho-ROCK signaling, J. Neurosci., 29, 11226, 10.1523/JNEUROSCI.6150-08.2009 · DOI
  40. Chen, 2010, Endolysosome mechanisms associated with Alzheimer's disease-like pathology in rabbits ingesting cholesterol-enriched diet, J. Alzheimers Dis., 22, 1289, 10.3233/JAD-2010-101323 · DOI
  41. Ray, 2012, Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling, Cell Signal, 24, 981, 10.1016/j.cellsig.2012.01.008 · DOI · Paper page
  42. Lim, 2001, The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse, J. Neurosci., 21, 8370, 10.1523/JNEUROSCI.21-21-08370.2001 · DOI · Paper page
  43. Li, 2004, Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice, J. Neurochem., 89, 1308, 10.1111/j.1471-4159.2004.02455.x · DOI
  44. Dumont, 2009, Reduction of oxidative stress, amyloid deposition, and memory deficit by manganese superoxide dismutase overexpression in a transgenic mouse model of Alzheimer's disease, FASEB J., 23, 2459, 10.1096/fj.09-132928 · DOI · Paper page
  45. Mari, 2009, Mitochondrial glutathione, a key survival antioxidant, Antioxid. Redox Signal., 11, 2685, 10.1089/ars.2009.2695 · DOI
  46. Giannakopoulos, 2003, Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease, Neurology, 60, 1495, 10.1212/01.WNL.0000063311.58879.01 · DOI · Paper page
  47. Nagy, 1995, Relative roles of plaques and tangles in the dementia of Alzheimer's disease: correlations using three sets of neuropathological criteria, Dementia, 6, 21
  48. Mocanu, 2008, The potential for beta-structure in the repeat domain of tau protein determines aggregation, synaptic decay, neuronal loss, and coassembly with endogenous Tau in inducible mouse models of tauopathy, J. Neurosci., 28, 737, 10.1523/JNEUROSCI.2824-07.2008 · DOI · Paper page
  49. Duyckaerts, 2008, Alzheimer disease models and human neuropathology: similarities and differences, Acta Neuropathol., 115, 5, 10.1007/s00401-007-0312-8 · DOI · Paper page
  50. Distl, 2003, Cholesterol storage and tau pathology in Niemann-Pick type C disease in the brain, J. Pathol., 200, 104, 10.1002/path.1320 · DOI
  51. Auer, 1995, Paired helical filament tau (PHFtau) in Niemann-Pick type C disease is similar to PHFtau in Alzheimer's disease, Acta Neuropathol., 90, 547, 10.1007/BF00318566 · DOI
  52. Bu, 2002, Deregulation of cdk5, hyperphosphorylation, and cytoskeletal pathology in the Niemann-Pick type C murine model, J. Neurosci., 22, 6515, 10.1523/JNEUROSCI.22-15-06515.2002 · DOI
  53. Liu, 2009, Reversal of defective lysosomal transport in NPC disease ameliorates liver dysfunction and neurodegeneration in the npc1-/- mouse, Proc. Natl Acad. Sci. USA, 106, 2377, 10.1073/pnas.0810895106 · DOI
  54. Davidson, 2009, Chronic cyclodextrin treatment of murine Niemann-Pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression, PLoS One, 4, e6951, 10.1371/journal.pone.0006951 · DOI
  55. Kowall, 1987, Axonal disruption and aberrant localization of tau protein characterize the neuropil pathology of Alzheimer's disease, Ann. Neurol., 22, 639, 10.1002/ana.410220514 · DOI
  56. Delacourte, 1990, Pathological proteins Tau 64 and 69 are specifically expressed in the somatodendritic domain of the degenerating cortical neurons during Alzheimer's disease. Demonstration with a panel of antibodies against Tau proteins, Acta Neuropathol., 80, 111, 10.1007/BF00308912 · DOI
  57. Cowan, 2012, What is the pathological significance of tau oligomers?, Biochem. Soc. Trans., 40, 693, 10.1042/BST20120135 · DOI
  58. Bolmont, 2007, Induction of tau pathology by intracerebral infusion of amyloid-beta -containing brain extract and by amyloid-beta deposition in APP x Tau transgenic mice, Am. J. Pathol., 171, 2012, 10.2353/ajpath.2007.070403 · DOI · Paper page
  59. Hernandez, 2009, Tau phosphorylation by cdk5 and Fyn in response to amyloid peptide Abeta (25–35): involvement of lipid rafts, J. Alzheimers Dis., 16, 149, 10.3233/JAD-2009-0933 · DOI · Paper page
  60. Schenck, 2008, The endosomal protein Appl1 mediates Akt substrate specificity and cell survival in vertebrate development, Cell, 133, 486, 10.1016/j.cell.2008.02.044 · DOI
  61. Garcia-Ruiz, 2009, Mitochondrial cholesterol in health and disease, Histol. Histopathol., 24, 117
  62. Garcia-Ruiz, 2012, Statins and protein prenylation in cancer cell biology and therapy, Anticancer Agents Med. Chem., 12, 303, 10.2174/187152012800228715 · DOI
  63. Eckert, 2009, Regulation of the brain isoprenoids farnesyl- and geranylgeranylpyrophosphate is altered in male Alzheimer patients, Neurobiol. Dis., 35, 251, 10.1016/j.nbd.2009.05.005 · DOI
  64. Hamano, 2012, Pitavastatin decreases tau levels via the inactivation of Rho/ROCK, Neurobiol. Aging, 33, 2306, 10.1016/j.neurobiolaging.2011.10.020 · DOI · Paper page
  65. Juottonen, 1998, Volumes of the entorhinal and perirhinal cortices in Alzheimer's disease, Neurobiol. Aging, 19, 15, 10.1016/S0197-4580(98)00007-4 · DOI
  66. Delacourte, 1999, The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease, Neurology, 52, 1158, 10.1212/WNL.52.6.1158 · DOI · Paper page
  67. Clausen, 2012, Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline, J. Alzheimers Dis., 30, 183, 10.3233/JAD-2012-111298 · DOI
  68. von Montfort, 2012, Mitochondrial GSH determines the toxic or therapeutic potential of superoxide scavenging in steatohepatitis, J. Hepatol., 57, 852, 10.1016/j.jhep.2012.05.024 · DOI · Paper page
  69. Tietze, 1969, Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues, Anal. Biochem., 27, 502, 10.1016/0003-2697(69)90064-5 · DOI
  70. Duncan, 1979, Determination of free, total, and esterified cholesterol by high-performance liquid chromatography, J. Chromatogr., 162, 281, 10.1016/S0378-4347(00)81515-7 · DOI
  71. Greenberg, 1990, A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis, Proc. Natl Acad. Sci. USA, 87, 5827, 10.1073/pnas.87.15.5827 · DOI
  72. Schmued, 1997, Fluoro-Jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration, Brain Res., 751, 37, 10.1016/S0006-8993(96)01387-X · DOI
  73. Morris, 1984, Developments of a water-maze procedure for studying spatial learning in the rat, J. Neurosci. Methods, 11, 47, 10.1016/0165-0270(84)90007-4 · DOI · Paper page
  74. Bevins, 2006, Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study ‘recognition memory, Nat. Protoc., 1, 1306, 10.1038/nprot.2006.205 · DOI

Cited by

Sorted by citations

Metadata

Authors
Barbero-Camps, E., Fernández, A., Martínez, L., Fernández-Checa, J. C., & Colell, A.
Venue
Human Molecular Genetics
Publisher
Oxford University Press (OUP)
Published
2013-05-06
Volume
22
Issue
17
Pages
3460-3476
ISSN
  • 1460-2083
  • 0964-6906
DOI
10.1093/hmg/ddt201
Cited by
114
References
12
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review